Timothy Plan International ETF (TPIF) news
Recent news
Biocon's Shaw: Biosimilars a very attractive segment
Biocon, India’s largest biopharmaceutical company, has positioned itself as a key player in the global biosimilars market, with its chairman and managing director, Kiran Mazumdar-Shaw, emphasizing the segment’s growing potential. The company recently received approval for its Glargine biosimilar in…
AInvest Wire · 4h agoJSE: BYI - Results for the six months ended 31 August 2026 and declaration of cash dividend
AInvest Wire · 7h agoCannabis stocks rose in premarket trading, with Green Thumb Industries up 16%, IGC Biosciences gaining 3.93% and Canopy Growth rising 2.77%.
Cannabis stocks experienced gains in premarket trading on October 12, 2026, with Green Thumb Industries (GTBIF) rising 16% following a series of recent developments, including the expansion of its retail footprint in Florida and Nevada. The company recently opened its 25th Florida location, RISE…
AInvest Wire · 1d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.